Budget Amount *help |
¥5,590,000 (Direct Cost: ¥4,300,000、Indirect Cost: ¥1,290,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2012: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Outline of Final Research Achievements |
Treatment with RANKL induces osteoclastogenesis in murine and canine bone marrow cells as well as murine RAW264.7 cells. Analyses of Mitf isoform expression indicated that Mitf-E gene was induced within 24 hours after RANKL treatment in all examined cells. Knockdown of Mitf-E by its siRNA transfection inhibited RANKL-induced osteoclastogenesis. In mouse cells, co-treatment with TGF-β enhanced RANKL-induced osteoclastogenesis, whereas TGF-β inhibited canine osteoclastogenesis induced by RANKL.
|